PROF
NASDAQProfound Medical
$6.91
+1.23 (+21.65%)
Institutional
45.0%
Insider
4.09%
Retail/Other
50.9%
Shares Outstanding
36.5M
Top Institutional Holders
As of Oct 2026| Holder | Shares | % | Change |
|---|---|---|---|
| Fidelity International Ltd | 2.4M | 6.5% | +0.0M |
| Gagnon Securities LLC | 2.0M | 5.4% | +0.0M |
| Royce & Associates, LP | 1.2M | 3.3% | +0.1M |
| Timelo Investment Management Inc. | 1.1M | 3.1% | - |
| Gagnon Advisors, LLC | 962K | 2.6% | - |
| Letko, Brosseau & Associates Inc. | 936K | 2.6% | -0.0M |
| Arnhold & S. Bleichroeder Advisers, LLC | 880K | 2.4% | +0.6M |
| Rosalind Advisors, Inc. | 828K | 2.3% | - |
| Z3 Capital Partners, LLC | 821K | 2.2% | +0.0M |
| Alyeska Investment Group, L.P. | 679K | 1.9% | +0.7M |
Insider Transactions
Last 24 months (1 insiders)
Arun Swarup Menawat
CEO
587,089 shares
Buys (2)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 12,027 | $4.73 | $56,888 | 2025-05-16 | 587,089 |
| 10,003 | $4.33 | $43,263 | 2025-05-15 | 575,062 |
Insider Activity Summary
Last 24 monthsTotal Bought
22,030 shares
$100,151
Total Sold
0 shares
$0
Net Shares
+22,030
Net Value
$+100,151
Activity by Insider
| Name | Bought | Sold | Net Shares | Net Value |
|---|---|---|---|---|
|
Arun Swarup Menawat
CEO
|
+22,030 | - | +22,030 | $+100,151 |
Net insider buying: 22,030 shares ($100,151) in last 12 months
Congressional Trading
STOCK Act DisclosuresNo congressional trading data available for this ticker.
Congressional trading data is sourced from STOCK Act disclosures and may not be available for all tickers.
Based on public disclosures. Reporting errors by representatives are common. Disclosure deadlines are 45 days after transaction.